我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

黄芪甲苷Ⅳ对梗死小鼠心肌新生血管成熟及HIF-1α、VEGF蛋白表达的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2017年第3期
页码:
269-275
栏目:
基础研究
出版日期:
2017-01-25

文章信息/Info

Title:
Effect of astragaloside IV on angiogenesis maturity in mice with myocardial infarction
作者:
李军昌1司静文13刘海涛2朱芳红1王 文1马 静1王宗仁1
第四军医大学西京医院:1.中医科,2.心脏内科,陕西 西安 710032;3.清华大学药学院,北京 100084
Author(s):
LI Jun-chang1 SI Jing-wen13 LIU Hai-tao2 ZHU Fang-hong1 WANG Wen1 MA Jing1 WANG Zong-ren1
1.Department of Traditional Chinese Medicine, 2.Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China; 3.School of Pharmaceutical Sciences, Tsinghua University, 100084, Peking, China
关键词:
黄芪甲苷ⅣHIF-1α血管新生血管成熟心肌梗死
Keywords:
astragaloside IV hypoxia-induced factor 1α angiogenesis maturity myocardial infarction
分类号:
R285.5
DOI:
-
文献标识码:
A
摘要:
目的 观察黄芪甲苷(Astragaloside,Astra)-Ⅳ对梗死小鼠心肌新生血管成熟及缺氧诱导因子(Hypoxia induced factor,HIF)-1α和血管内皮生长因子(Vascular endothelial cell factor,VEGF)蛋白表达的影响。方法 结扎法制备小鼠心肌梗死(Myocardium Infarct,MI)模型,Astra-Ⅳ腹腔注射〔2 mg/(kg·d)〕21 d,通过小动物超声系统评价小鼠心功能;计算梗死面积(IS)与缺血区面积(AAR)的比值;CD31和α-SMA双荧光染色法观察梗死周边心肌组织新生和成熟血管密度;经鼠尾注射FITC-Lectin观察新生血管的灌注情况;Western blot检测MI区及其边缘组织HIF-1α、VEGF表达的变化。结果 Astra-Ⅳ可提高小鼠的FS(%)和EF(%)〔(61.0±2.7)% vs.(40.2±3.9)%,P<0.05;(44.1±3.2)% vs.(29.1±4.1)%,P<0.05〕,减少MI范围〔28.8±8.4)% vs.(45.1±9.3)%;P<0.05〕;MI+Astra-Ⅳ组心肌新生血管密度(214.0±21.3/mm2),成熟血管密度(7.0±2.1/mm2),有效灌注新生血管密度为(0.39±0.11)×105/pixels,与MI组比较均具有显著差异(P<0.01);MI+Astra-Ⅳ组显著增加周围组织的HIF-1α、VEGF蛋白水平(P<0.01)。结论 Astra-Ⅳ缩小MI面积,提高梗死心肌功能,并促进促血管新生和成熟,实现缺血组织有效灌注,其分子机制可能与HIF-1α和VEGF蛋白的表达增加有关。
Abstract:
AIM To investigate the effect of astragaloside IV on angiogenesis maturity in mice with myocardial infarction (MI) and protein expression of hypoxia-induced factor 1α and vascular endothelial cell factor. METHODS C57BL mice were randomly divided into three groups: sham, myocardial infarction (MI model) and astragaloside IV therapy (Astra-MI). MI mice were established by permanent coronary artery ligation. Astragaloside IV (2 mg/kg/day) was administrated intraperitoneally every day for 21 days. Left ventricular ejection fraction and fractional shortening were determined by Animal Visual Sonics System (Canada). Areas at risk and infarct size were determined by Evan's blue and triphenyl tetrazolium chloride (TTC) methods. CD31 and α-SMA fluorescent staining were used to observe the density of angiogenesis and maturity of vessels in the peri-infarction myocardium tissue. Fusion angiogenesis density was determined by FITC-lectin fluorescent staining. Expressions of HIF-1α and VEGF were determined by Western blot. RESULTS Left ventricular ejection fraction and fractional shortening were significantly improved in Astra-MI group, respectively, compared with those in MI model control [(61.0±2.7)% vs.(40.2±3.9)%, P<0.05; (44.1±3.2)% vs.(29.1±4.1)%, P<0.05]. IS/AAR were significantly attenuated in Astra-MI group [(28.8±8.4)% vs.(45.1±9.3)%, P<0. 05]. Angiogenesis density, vessel maturity and fusion angiogenesis in peri-infarction myocardium tissues in Astra-MI group were (214.0±21.3)/mm2, (7.0±2.1)/mm2, and (0.39±0.11)×104/pixels, respectively, which were all significantly better than those in the control group (P<0.01). Protein expressions of HIF-1α and VEGF in the risk area of MI in Astra-MI group were higher than in controls (P<0.01). CONCLUSION Astragaloside IV may reduce ischemia injury and improve function by improving effective angiogenesis density in mice with MI. The mechanism of astragaloside IV may be related with increasing HIF-1α and VEGF expressions.

参考文献/References

[1]Ferrara N,Kerbel RS.Angiogenesis as a therapeutic target[J].Nature,2005,438(7070):967-974.
[2]孙帅玲,赵 维,谢雁鸣,等.真实世界3626例急性心肌梗死患者中医临床特征探析[J].辽宁中医杂志,2016,43(3):452-454.
[3]朱明丹,杜武勋,姜 民,等.心肌梗死恢复期气虚血瘀证的代谢组学研究[J].时珍国医国药,2016,27(6):1527-1530.
[4]洪海都,温俊茂,陈宗俊.黄芪主要活性成分的药理作用研究进展[J].世界最新医学信息文摘,2016,16(14):49-50,69.
[5]Zhang WD,Chen H,Zhang C,et al.Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro[J].Planta Med,2006,72(1):4-8.
[6]Liebson PR.Stem-cell angiogenesis and regeneration of the heart: review of a saga of 2 decades[J].Clin Cardiol,2015,38(5):309-316.
[7]Lee MS,Park HS,Lee BC,et al.Identification of Angiogenesis Rich-Viable Myocardium using RGD Dimer based SPECT after Myocardial Infarction[J].Sci Rep,2016,6:27520.
[8]王承龙,史大卓,王 强,等.运用Markov模型评价益气活血中药干预不稳定性心绞痛远期疗效的探索[J].中国中西医结合杂志,2014,34(4):406-411.
[9]衣 慧,王俊超,司静文,等.芪丹通脉片对心肌梗死大鼠缺血心肌血管新生及HIF-1α、VEGF表达的影响[J].中国中医急症,2013,22(5):689-695.
[10]Katare RG,Madeddu P.Pericytes from human veins for treatment of myocardial ischemia[J].Trends Cardiovasc Med,2013,23(3):66-70.
[11]Resar JR,Roguin A,Voner J,et al.Hypoxia-inducible factor 1alpha polymorphism and coronary collaterals in patients with ischemic heart disease[J].Chest,2005,128(2):787-791.
[12]Hinkel R,Lebherz C,Fydanaki M,et al.Angiogenetic potential of Ad2/Hif-1α/VP16 after regional application in a preclinical pig model of chronic ischemia[J].Curr Vasc Pharmacol,2013,11(1):29-37.
[13]Heinl-Green A,Radke PW,Munkonge FM,et al.The efficacy of a 'master switch gene' HIF-1alpha in a porcine model of chronic myocardial ischaemia[J].Eur Heart J,2005,26(13):1327-1332.
[14]李军昌,王宗仁,李秋霞,等.PI3K/Akt信号通路介导芪丹通脉片抑制缺血再灌注大鼠心肌细胞凋亡[J].中国现代医学,2007,17(10):1183-1185.
[15]Zhang L,Liu Q,Lu L,et al.Astragaloside IV stimulates angiogenesis and increases hypoxia-inducible factor-1α accumulation via phosphatidylinositol 3-kinase/Akt pathway[J].J Pharmacol Exp Ther,2011,338(2):485-491.
[16]田景平,吕爱平.常用补气、活血、破血药对治疗冠心病的分子机制预测[D].广州:广州中医药大学, 2013:16-63.
[17]胡晶晶,范雪梅,孟宪生,等.应用基因表达谱芯片研究中医复方对心肌梗死的药效机制[J].辽宁中医药大学学报,2014,16(7):79-82.
[18]Si J,Wang N,Wang H,et al.HIF-1α Signaling Activation by Post-Ischemia Treatment with Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury[J].PLoS One,2014,9(9):e107832.

备注/Memo

备注/Memo:
收稿日期:2016-09-05.基金项目:国家自然科学基金项目资助(81072972);第四军医大学科技发展基金项目资助(2016XC215) 通讯作者:李军昌,副主任医师,主要从事中西医结合心血管病研究Email:lijunch@fmmu.edu.cn
更新日期/Last Update: 2017-02-20